Archives

img-01

China Requires Electronic Filing for GMP Certification

China’s Food and Drug Administration (CFDA) announced on August 23 that all applicants for GMP certification for pharmaceutical products must now submit their materials electronically. According to the Chinese language notification, materials must be submitted to the website of the Center for... Read More

img-01

The In-Vitro Diagnostics Market in China

China's in-vitro diagnostics (IVD) market is among the fastest growing in the world, with recent annual growth rates of more than 18 percent. In 2007, China made up just 3 percent of the global IVD market. Today, it makes up 8 percent.... Read More

img-01

Asia: Diagnostic Imaging Boom

Asia’s diagnostic imaging market is growing faster than that of any global region, as Asians — especially older ones — are spending more of their disposable income on healthcare.  According to a recent report released by Frost & Sullivan, more than 30... Read More

img-01

China Enforces New Quality Control Standards for Drugs

Starting July 1, 2013, all new pharmaceutical companies operating in China must comply with China’s Food and Drug Administration (CFDA) revised Drug Quality Control Standards for license approval and GMP certification. Pharmaceutical companies with new, expanded or renovated warehouses or business locations... Read More

img-01

Asia’s Diagnostic Imaging Market

Asia's diagnostic imaging market is growing faster than in any other global region. It is expanding at an annual rate of 11 percent, compared to just 7 percent in the rest of the world. In 2012, the Asian diagnostic imaging market was... Read More